D-0391-2026 Class III Ongoing
FDA drug recall D-0391-2026 was initiated by Annora Pharma Private Limited on Feb 3, 2026 and is designated Class III. Reason for recall: Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg The recall status is ongoing. Affected quantity: 770 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 25, 2026
- Initiation Date
- Feb 3, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 770 bottles
Product description
Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Pharma Pvt. LTd., Sengareddy - 502313, Telengana, India, NDC 72603-479-01.
Reason for recall
Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg
Distribution pattern
TN
Code information
Lot #: A252487, Exp 05/31/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0391-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026